A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever

<strong>Background<br></strong> Only one recommendation currently exists for the treatment of Lassa fever (LF), which is ribavirin administered in conjunction with supportive care. This recommendation is primarily based on evidence generated from a single clinical trial that was co...

Full description

Bibliographic Details
Main Authors:	Olayinka, AT, Bourner, J, Akpede, GO, Okoeguale, J, Abejegah, C, Ajayi, NA, Akude, C, Ayodeji, O, Bausch, DG, de Clerck, H, Dan-Nwafor, C, Dunning, J, Erameh, C, Eze, JN, Formenty, P, Gillesen, A, Jalloh, S, Jaspard, M, Jegede, T, Maikere, J, Malvy, D, Ogbaini-Emovon, E, Ojo, OE, Okogbenin, S, O'Neill, K, Orji, M-L, Owhin, SO, Ramharter, M, Samuels, RJ, Shehu, N, Merson, L, Salam, AP, Kayem, ND, Horby, P, Ihekweazu, C, Olliaro, P
Format:	Journal article
Language:	English
Published:	Public Library of Science 2022

A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever

Similar Items